ToniLymphe Jambes légères
Food supplement declared in France, declaration No 2021-7-484
ToniLymphe Jambes légères is a food supplement declared in France. Status: withdrawn from the market on 31 October 2025. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- BOUCHARA-RECORDATI
- Status
- Withdrawn from the market on 31 October 2025
- Form
- Capsule
- Daily dose
- 2 gélules/Jour
- Directions for use
- 2 Gélules par jour au cours des repas, de préférence le matin avec un verre d'eau
- Not recommended (according to the manufacturer)
- Children (under 12), Pregnant women, Taking anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Blood and lymphatic circulation
Declaration 264334, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Aesculus hippocastanum L. | Graine | Extrait sec hydroalcoolique | 120 mg |
| Vitis vinifera L. | Feuille | Extrait sec aqueux | 90 mg |
| Ruscus aculeatus L. | Racine | Extrait sec hydroalcoolique | 40 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Acide L-ascorbique | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
| Succinate acide de D-alpha-tocophéryle | Vitamine E | 300 mg | 30 mg |
Additives
E470b, E464
Other ingredients
Bambusa bambos (L.) Voss, amidon de maïs, maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ce produit n'est pas destiné aux enfants de moins de 12 ans. L'emploi chez les personnes sous traitement anticoagulant est déconseillé. L'emploi chez les femmes enceintes est déconseillé. Avant toute supplémentation, les femmes allaitantes devront prendre l'avis d'un professionnel de santé
Regulatory points
- Information
Withdrawn from the market on 31 October 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Aesculus hippocastanum L.
Read the warning, when it applies and the studies cited
Horse Chestnut - Aesculus Hippocastanum
Route of administration: Oral (Bradley 2006; ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.